Prostate-specific Antigen at 3 Months as a Predictor of Radiologic Progression-free Survival in Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Analysis of 633 Patients in a Real-world Database
Hassi Roman, Mario, Mate, Kinga, De Pablos-Rodriguez, Pedro, Horcajada, Álvaro Zamora, Cascales, Ana Guijarro, Bonet, Ángeles Sanchís, Vilaseca, Antoni, Vázquez-Martul Pazos, Darío, Espinós, Estefanía Linares, Rodríguez, Jesús Muñoz, de la Morena Gallego, José Manuel, Alemán, José Ramón, Rivas, Juan Gómez, Formisano, Luigi, Juan Fita, Maria J., Planells, Marc Costa, Esteban, Mario Domínguez, Márquez, Meritxell Pérez, Sanz, Miguel García, Expósito, Nagore García, Picola, Natalia, Vives, Pol Servian, Sutil, Raquel Sopeña, Climent Durán, Miguel A., Backhaus, Miguel Ramírez
Published in European urology open science (Online) (01.12.2024)
Published in European urology open science (Online) (01.12.2024)
Get full text
Journal Article
Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre study
López-Abad, Alicia, Ramírez Backhaus, Miguel, Server Gómez, Gerardo, Cao Avellaneda, Enrique, Moreno Alarcón, Cristóbal, López Cubillana, Pedro, Yago Giménez, Pablo, de Pablos Rodríguez, Pedro, Juan Fita, María J., Climent Durán, Miguel Á., Guardiola Ruiz, Iris, Vidal Crespo, Natalia, Artés Artés, Miriam, Montoya Chinchilla, Raúl, Moreno Avilés, Juan, Guzmán Martínez-Valls, Pablo L., López González, Pedro Á.
Published in Prostate international (01.03.2024)
Published in Prostate international (01.03.2024)
Get full text
Journal Article